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Abstract
The treatment of envenomation with effective snake 
antivenom immunoglobins has become a critical worldwide 
health issue. Current methods for testing the effectiveness of 
new antivenom mixtures in neutralizing venom 
toxicity/lethality use animal models (e.g. mice).  Neutralization 
of venom toxicity/lethality requires the formation of venom-
antivenom immune complexes (though the extent of complex 
formation in vivo is unknown).  Size-exclusion high-performance 
liquid chromatography (SE-HPLC) is a reproducible quantitative 
method to characterize venom-antivenom immune complex 
formation in vitro within a relatively short time.  Changes in SE-
HPLC elution profiles due to dose-dependent formation of 
venom-antivenom immune complexes are presented for 1) 
Crotalis atrox (western diamondback rattlesnake) venom and 
the current antivenom used clinically in North America [FabAV
(Ovine); CroFab™], and 2) Bothrops jararaca venom (Brazil) and 
Bothropic antivenom [F(ab’)2AV (Equine); Brazil].  Changes in 
profile region areas were fit to a hyperbolic dose-response 
function to estimate maximum binding and venom/antivenom 
concentrations at half-maximum binding. 
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Materials and Methods
Equipment:
The HPLC system consisted of a Waters (Milford, MA) Model 515 
HPLC pump, a Waters 717plus Autosampler, a TSKgel
G3000SWXL (5 µm, 7.8 mm ID x 30 cm) SEC column (TOSOH 
Bioscience), and a Waters 2996 Photodiode Array Detector. 
Detector response was recorded using Empower 3 (Waters) 
acquisition software at a 1 ml/minute flow rate at room 
temperature in elution buffer [100 mM sodium phosphate (pH 
6.7) containing 0.10 M sodium sulphate].
Materials:
Antivenin: FabAV - Ovine Fab fragments (CroTABTM, 
Protherics Inc., Brentwood TN,USA); 
Mr ≈ 50 kDa; one binding site/molecule.
F(ab’)2AV - Equine F(ab’)2 fragments (Bothropic
antivenom, Butantan Institute, San 
Paulo, SP, Brazil); Mr ≈ 100 kDa; 
two binding sites/molecule.
Venoms:   Crotalus atrox (Western diamondback 
rattlesnake), Sigma (St. Louis, MO, USA)
Bothrops jararaca (Brazilian arrowhead viper), 
via Rita Collaço
Samples:   Venom, antivenom, and mixtures of antivenom 
containing varying concentrations of venom were incubated at 
37°C for 30 minutes prior to SEC analysis. Sample injection 
volume = 20 µl 
Analysis:   Changes in profile region areas were fit to hyperbolic 
dose-response functions using SigmaPlot to estimate maximum 
binding and venom/antivenom concentrations at half-maximum 
binding.
Summary
SE-HPLC is a method that is readily available and can be applied using 
common HPLC system components. Samples can be analyzed under 
conditions that preserve the structure and function of antigens and 
antibodies. Immune complex formation can be quantified, and dose-
response parameters can be determined that reflect binding affinity (e.g. 
C50) and maximum antibody reactivity (e.g. maximum CPLX area). 
Venom:antivenom immune complex formation was analyzed by quantitating 
changes in SE-HPLC elution profiles of reaction mixtures compared to venom 
and antivenom control profiles. Three regions were chosen for integration. 
Region 1 increased due to immune complex formation, Region 2 decreased 
due to decreased reactant concentrations, and Region 3 did not change 
during complex formation (non-binding).
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